Evaluating covid-19 vaccine efficacy and safety in the post-authorisation phase

Expedited approval pathways have been increasingly used over the past 30 years to bring new medicines to market. The basic premise has been to give patients earlier access to medicines, often…

Read Original Article: Evaluating covid-19 vaccine efficacy and safety in the post-authorisation phase »